Clinical studies recruiting near Mannheim

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Universitätsklinikum Mannheim GmbH · Takeda · NCT06747351 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Universitätsklinikum Mannheim GmbH · AGO Study Group · NCT05009082 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Universität Mannheim · Hoffmann-La Roche · NCT06793215 Endometrial Cancer Lymphadenectomy Trial
NA · Klinikum Mannheim GmbH, Universitäts-Frauenklinik · Philipps University Marburg · NCT03438474 European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]
Phase 2 · Universitätsklinikum Mannheim, Klinik für Hals-Nasen-Ohrenhe · University of Leipzig · NCT06137378 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Universitaetsklinikum Mannheim · Janssen Research & Development, LLC · NCT07499232 DEfeating PEnile CAncer-2
NA · Medical Faculty Mannheim · University Hospital Tuebingen · NCT07378670 International HIT-MED Registry (I-HIT-MED)
Phase N/A · University Hospital Mannheim · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Phase 2/Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05948943 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Klinikum Mannheim · Goethe University · NCT02872987 Early Catheter-directed Treatment of High Risk Pulmonary Embolism
NA · Universitätsklinikum Mannheim · Leipzig Heart Science gGmbH · NCT06672081 Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
Phase 4 · Universitätsmedizin Mannheim, II. Medizinische Klinik · University of Leipzig · NCT05551299 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Universitatsklinikum Mannheim /ID# 238331 · AbbVie · NCT04928846 Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
Phase 2 · Klinikum Mannheim gGmbH · Technische Universität Dresden · NCT05904106 Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab
Phase 2 · Universitätsklinikum Mannheim · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT07387198 Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN Grade-II, to Reduce Symptom
Phase 3 · Medizinische Fakultät Mannheim der Uniklinik Heidelberg · WALA Heilmittel GmbH · NCT06186479 A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
Phase 3 · University Hospital Mannheim, Neurology Clinic · University Hospital Heidelberg · NCT05331521 Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation
NA · Universitätsmedizin Mannheim · Insel Gruppe AG, University Hospital Bern · NCT05976685 Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment
Phase 2 · Central Institute of Mental Health, Department of Psychiatry · Central Institute of Mental Health, Mannheim · NCT06881810 A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06830720 Brain Signal Training to Enhance Affect Down-regulation
Phase 1/Phase 2 · Central Institute of Mental Health · Central Institute of Mental Health, Mannheim · NCT06626789 Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
Phase 2 · Department of Radiation Oncology, Medical Faculty Mannheim · University Hospital Tuebingen · NCT05871021 A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Phase 3 · Universitätsklinikum Mannheim GmbH · Verastem, Inc. · NCT06072781 Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder
NA · Central Institute of Mental Health · Central Institute of Mental Health, Mannheim · NCT06105853 Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy
Phase 2 · Universitätsklinikum Mannheim · Artcline GmbH · NCT05442710 A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and Wi
Phase 1 · CRS Mannheim · BioNTech SE · NCT07392372 A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treat
Phase 3 · Research Site · AstraZeneca · NCT06764875 Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Te
Phase 1/Phase 2 · Universitätsklinikum Mannheim GmbH · Boehringer Ingelheim · NCT06324357 MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Phase 3 · Universitätsklinikum Mannheim · Swiss GO Trial Group · NCT04111978

Look up another city

Look up another condition